Lionheart Health, Inc.
Unlocking the Body’s Innate Repair Programs

The human body possesses a remarkable, yet often dormant ability to heal itself. Genes for essential proteins, such as VEGF (which promotes blood vessel growth), IGF-1 (which rebuilds muscle), and Klotho (which protects vital organs), are hardwired into our DNA, waiting for the right signals to activate them. However, in the face of chronic disease or injury, these signals fade, and the body’s repair systems falter. Instead of regenerating, we form scar tissue, which weakens organs and diminishes resilience.

Lionheart Health, Inc. has developed a groundbreaking solution: a bioelectric system designed to activate these natural repair programs. The technology combines tiny, battery-free micro-implants with external power discs to deliver precise electrical sequences. These bioelectric signals act as a wake-up call, prompting tissues to produce their own healing proteins and effectively restarting the body’s natural repair toolkit.

A MULTI-FACETED APPROACH TO ORGAN REGENERATION

To amplify the bioelectric effect, the company employs a multi-pronged strategy. The micro-implants are often paired with a refillable micro-infusion pump for targeted delivery of nutrients and growth factors, hydrogel scaffolds to maintain cell presence at the injury site, and even specially engineered stem cells that secrete protective proteins. Together, these components not only reawaken repair pathways but also provide the necessary support for proper regeneration.

“We believe we’re on the right track,” says Howard J. Leonhardt, Executive Chairman and CEO. “Drugs alone can’t get us there, but the right bioelectric signals in the right places can. We want to offer total regeneration for all organs, from hearts and kidneys to pancreases and skin.”

FROM CARDIAC CARE TO WHOLE-BODY REJUVENATION

This “signal first, sustain with support” model is proving to be a versatile platform, adaptable across different organs. In the heart, for example, bioelectric signals prompt cells to release VEGF and IGF-1, restoring circulation and rebuilding muscle where scar tissue had formed. The result is damaged tissue that begins to function more like healthy tissue.

Lionheart is actively developing a pipeline of organ-specific therapies, including:

● KidneyCell^™ to boost levels of the protective Klotho protein.
● BladderCell^™ (B-Alive^™) for bladder function.
● ErectiStim^™ for erectile dysfunction, which has already shown promising clinical results, with an 89% improvement in 115 patients lasting over a year.

The same foundational technology is being adapted for EyeCell^™ (vision), LiverCell^™ (hepatic regeneration), PancreaCell^™ (pancreatic support), and CerebraCell^™ (neurodegenerative conditions). A prime example of this versatility is the Klotho implant system, designed to connect to an external controller and app, giving patients direct control over their therapy.

THE ROAD TO A “TOTAL REGENERATION CHAMBER”

Lionheart is not trying to solve every problem at once. Instead, it follows a meticulous, step-by-step approach, testing and validating each component under the oversight of regulatory bodies like the FDA. The long-term vision, however, is extraordinary: what Leonhardt calls the Total Regeneration Chamber. This AI-managed, robotics-assisted “womb for adults” would be capable of treating multiple organs simultaneously, pushing medicine beyond symptom control toward genuine restoration.

While the chamber remains under development, specific components of the technology are already available on the market. The company has partnered with OEM manufacturers to offer FDA-cleared devices that apply its core technology to applications such as muscle strengthening, arthritis therapy, and clot prevention. Its BodStim^™ Suit, a wearable system, uses similar bioelectric stimulation to enhance exercise and support muscle health as we age.

The team behind these innovations blends deep engineering and medical expertise. Chief Technology Officer Brian Lassater has driven over a hundred design breakthroughs, enabling the creation of ultra-small implants. Meanwhile, Leonhardt brings decades of experience in regenerative medicine. Together, they are on a mission to move medicine beyond symptom management and toward truly restoring the human body.